HOME >> MEDICINE >> NEWS
Gene targeting prevents memory loss in Alzheimer's disease model

CHICAGO --- Northwestern University researchers have prevented learning and memory deficits in a model of Alzheimer's disease using a gene-targeting approach to block production of beta-amyloid, or "senile," plaques, one of the hallmarks of the disease.

Alzheimer's disease is a neurodegenerative condition affecting over 15 million people worldwide that causes memory loss and, ultimately, dementia. Some research suggests that Alzheimer's disease is caused by an increased amyloid burden in the brain -- the so-called amyloid cascade hypothesis.

Results of the Northwestern study, published in the January issue of the journal Neuron, provide compelling evidence for the therapeutic potential of inhibiting an enzyme, beta-secretase (BACE1), required for the production of beta-amyloid, to treat memory impairment in patients with Alzheimer's disease.

The study also presents new evidence that beta-amyloid is directly responsible for causing the memory-robbing effects of Alzheimer's disease, said Masuo Ohno, research assistant professor of physiology, Feinberg School of Medicine at Northwestern University. Ohno's co-researchers on the project were John F. Disterhoft, professor of physiology, and Robert Vassar, associate professor of cell and molecular biology at the Feinberg School.

Ohno and colleagues used behavioral, biochemical and electrophysiologic methods to analyze BACE1 in mice bred to lack the enzyme but to also overproduce amyloid precursor protein, which BACE1 "clips" into fragments of beta-amyloid that eventually form the notorious plaques associated with Alzheimer's disease.

The mice were healthy and had no serious neurological abnormalities, suggesting that BACE1 inhibition is a rational strategy for treating Alzheimer's disease, Ohno said.

Importantly, the beneficial effects of BACE1 inhibition in the mice were seen well before beta-amyloid plaques formed, indicating that the soluble forms of the protein can dis
'"/>

Contact: Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University
7-Jan-2004


Page: 1 2

Related medicine news :

1. Black cohosh may reduce hot flashes by targeting brains thermostat
2. New studies report AVANDIA may have the potential to reduce cardiovascular risk by targeting a fundamental cause of Type 2 diabetes
3. Screening for osteoporosis prevents hip fractures in older adults
4. Understanding how prostaglandin prevents gut injury during radiation therapy
5. Exercise prevents Parkinsons symptoms in lab model mimicking human form of the disease
6. Study finds once-daily Valcyte prevents serious viral infection after kidney transplant
7. Enzyme prevents lung damage in premature infants
8. Enoxaparin prevents stillbirth in pregnant women with clotting disorder
9. New drug prevents arrhythmias that cause sudden cardiac death
10. Detecting vitamin B12 deficiency prevents anaemia and memory loss
11. Drug prevents diabetes recurrence after islet cell transplantation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene targeting prevents memory loss Alzheimer disease model

(Date:5/25/2013)... According to a new market report,"Global Homeland Security ... is expected to reach $544.02 Billion by 2018 ... studies the major market drivers, restraints, and opportunities ... the World. , Browse:, , ... Figures , 175 Pages and in-depth ...
(Date:5/25/2013)... The Slim Weight Patch has been clinically proven ... due to the highly sought after ingredients that have been ... an extra 2 months supply & premium membership of Slimming+ ... body you desire faster than ever. , Click Here ... Slim weight patch consumers can observe instant results within only ...
(Date:5/25/2013)... May 25, 2013 Ayurveda is ... means "knowledge or wisdom of life". While a medical science, ... the transformation of consciousness. Its fundamental philosophy is that disease ... our environment. It believes that in order to re-establish optimal ... harmony and then adopt a life style which brings us ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The product ... an Imprelis lawsuit on behalf of 23 property ... N13C-04-280 EMD) was filed on April 25, 2013 and names ... with previously filed Wright & Schulte Imprelis lawsuits, this case ... Castle County. , This Imprelis lawsuit alleges ...
(Date:5/24/2013)... May 25, 2013 Part guidebook, part ... presenting a tried and true approach to meditation for ... to Mastering the 11th Step, the book outlines a ... understanding of the 11th step in any 12-step recovery ... and drug dependence an ever-growing global health problem affecting ...
Breaking Medicine News(10 mins):Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 2Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 3Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 4Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 2Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 3
(Date:5/24/2013)... England and BOSTON , May 24, ... discovery and development company, is pleased to announce that it has ... to augment the Company,s business development capabilities in Japan ... more than 15 years of experience in business development, licensing and ... Sciences, Inc., Roche Pharma ( Japan ), Nippon Roche ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... 23, 2013  Haemonetics Corporation (NYSE: HAE ) ... & EVP-Business Development, will present at The Deutsche Bank 38 ... Boston, MA on May 29, 2013 at 1:30pm ... The public may access Mr. Lindop,s presentation live ... Haemonetics Haemonetics (NYSE: HAE ) is ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
Cached News: